Tayyab Shah (@tayyabshahmd) 's Twitter Profile
Tayyab Shah

@tayyabshahmd

Cardiology Fellow, Outcomes Researcher

ID: 1893790435862007808

calendar_today23-02-2025 22:30:06

5 Tweet

7 Followers

62 Following

MyJSCAI (@myjscai) 's Twitter Profile Photo

📖Network metaanalysis for #endovascular intrvntions in #SFA disease. Newer endovascular techniques were superior to PTA regarding technical success, primary patency at 12m & symptom improvement #PAD doi.org/10.1016/j.jsca… Alexandra Lansky Sahil A. Parikh, MD Jay Giri @ACFanaroff

📖Network metaanalysis for #endovascular intrvntions in #SFA disease. Newer endovascular techniques were superior to PTA regarding technical success, primary patency at 12m & symptom improvement #PAD

doi.org/10.1016/j.jsca…

<a href="/AlexandraLansky/">Alexandra Lansky</a> <a href="/sahilparikhmd/">Sahil A. Parikh, MD</a> <a href="/jaygirimd/">Jay Giri</a> @ACFanaroff
American College of Cardiology (@accintouch) 's Twitter Profile Photo

In this week’s #EaglesEyeView, Dr. Kim Eagle explores: ✅ #SGLT2 Inhibitors & Aortic Valve Stenosis ✅ Early vs. Later Ablation for #AFib ✅ Sports Participation by Athletes with Cardiac Abnormalities 🎧 Tune in here: bit.ly/3DdoZwo

In this week’s #EaglesEyeView, Dr. <a href="/keaglemd/">Kim Eagle</a> explores:
✅ #SGLT2 Inhibitors &amp; Aortic Valve Stenosis
✅ Early vs. Later Ablation for #AFib 
✅ Sports Participation by Athletes with Cardiac Abnormalities

🎧 Tune in here: bit.ly/3DdoZwo
MyJSCAI (@myjscai) 's Twitter Profile Photo

🚨#SFA study of 57 trials & 9089 pts compared 9 treatments for Superficial Femoral Artery disease💡 @SahilParikhMD Khanjan Shah & AndrewSchwartz break down the study in this interview🎥 ➡️youtu.be/uO9-6uTUH2w 📖Read the article: doi.org/10.1016/j.jsca…

🚨#SFA study of 57 trials &amp; 9089 pts compared 9 treatments for Superficial Femoral Artery disease💡

 @SahilParikhMD <a href="/KhanjanShahMD/">Khanjan Shah</a> &amp; AndrewSchwartz break down the study in this interview🎥

➡️youtu.be/uO9-6uTUH2w

📖Read the article: doi.org/10.1016/j.jsca…
JACC Journals (@jaccjournals) 's Twitter Profile Photo

This #JACCINT retrospective, multicenter, observational study suggests that #SGLT2i may slow the progression of non-severe aortic stenosis! Check out the full paper here: jacc.org/doi/10.1016/j.… #vhdAS

This #JACCINT retrospective, multicenter, observational study suggests that #SGLT2i may slow the progression of non-severe aortic stenosis! Check out the full paper here: jacc.org/doi/10.1016/j.… #vhdAS
EuroIntervention (@eurointerventio) 's Twitter Profile Photo

New in EuroIntervention🔥 SCAI/EAPCI/ACVC expert consensus on cardiogenic shock in women. A comprehensive, evidence-based guide to diagnosis, monitoring, and treatment—across CS etiologies and clinical settings. #europcr #eapci #cardiogenicshock ow.ly/fAn250VVpLr

New in EuroIntervention🔥
SCAI/EAPCI/ACVC expert consensus on cardiogenic shock in women.
A comprehensive, evidence-based guide to diagnosis, monitoring, and treatment—across CS etiologies and clinical settings. #europcr #eapci #cardiogenicshock
ow.ly/fAn250VVpLr
MyJSCAI (@myjscai) 's Twitter Profile Photo

🆕🚨 New SCAI & #EAPCI expert consensus - #CardiogenicShock continues to disproportionately impact women, with care gaps worsening outcomes. 💡This consensus calls for #SexSpecific treatment needs, better data, & clear guidance to improve care for women w #CS

🆕🚨 New <a href="/SCAI/">SCAI</a> &amp; #EAPCI expert consensus - #CardiogenicShock continues to disproportionately impact women, with care gaps worsening outcomes. 

💡This consensus calls for #SexSpecific treatment needs, better data, &amp; clear guidance to improve care for women w #CS
Structural Heart (@crfshj) 's Twitter Profile Photo

🆕 meta-analysis: Early aortic valve replacement before severe symptomatic AS shows no significant benefit for most hard endpoints like mortality or MI but may reduce stroke. ow.ly/9cBp50W0VMB Tayyab Shah Alexandra Lansky Jeffrey Popma

🆕 meta-analysis: Early aortic valve replacement before severe symptomatic AS shows no significant benefit for most hard endpoints like mortality or MI but may reduce stroke. ow.ly/9cBp50W0VMB <a href="/TayyabShahMD/">Tayyab Shah</a> <a href="/AlexandraLansky/">Alexandra Lansky</a> <a href="/PopmaJeffrey/">Jeffrey Popma</a>
Alejandro Lemor MD, MS (@alejandrolemor) 's Twitter Profile Photo

Novel risk score for Impella-HRPCI to calculate in-hospital mortality. Easy to remember and can be useful to discuss risk of mortality with patients undergoing #HRPCI. 📌 sciencedirect.com/science/articl…

Novel risk score for Impella-HRPCI to calculate in-hospital mortality.   
Easy to remember and can be useful to discuss risk of mortality with patients undergoing #HRPCI. 
📌 sciencedirect.com/science/articl…
Jay Giri (@jaygirimd) 's Twitter Profile Photo

Renal denervation for HTN was approved the FDA over 18 months ago. But very few cases performed in the US despite a theoretical eligible population >100M patients for this therapy. We cover the elephant in the room: reimbursement in Cardiac Interventions Today. citoday.com/articles/2025-…